CSIMarket
 


Plx Pharma Inc   (PLXP)
Other Ticker:  
 
 

PLXP's Net Cash Flow Growth by Quarter and Year

Plx Pharma Inc 's Net Cash Flow results by quarter and year




PLXP Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -13.16 13.36 -4.51
III Quarter September -9.90 2.38 -4.17 -2.75
II Quarter June -16.77 -4.25 3.97 -3.06
I Quarter March -16.89 61.97 -4.71 10.07
FY   -43.56 46.94 8.45 -0.25



PLXP Net Cash Flow third quarter 2022 Y/Y Growth Comment
Plx Pharma Inc in the third quarter 2022 recorded net cash outflow of $ -9.90 millions.

According to the results reported in the third quarter 2022, Plx Pharma Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Plx Pharma Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2022.




PLXP Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - 455.5 % - -

Financial Statements
Plx Pharma Inc 's third quarter 2022 Net Cash Flow $ -9.90 millions PLXP's Income Statement
Plx Pharma Inc 's third quarter 2021 Net Cash Flow $ 2.38 millions Quarterly PLXP's Income Statement
New: More PLXP's historic Net Cash Flow Growth >>


PLXP Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - 363.85 % - -
FY (Year on Year)   - 455.5 % - -




Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Plx Pharma Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PLXP's III. Quarter Q/Q Net Cash Flow Comment
Even if Plx Pharma Inc in the III. Quarter 2022 showed net cash outflow of $ -9.90 millions, it should be said, that this show improvement compare to the -16.77 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Plx Pharma Inc achieved highest sequential Net Cash Flow growth. While Plx Pharma Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PLXP's III. Quarter Q/Q Net Cash Flow Comment
Although Plx Pharma Inc in the III. Quarter 2022 admitted net cash outflow of $ -9.90 millions, it should be point out, that current results point to improvement in contrast to the -16.77 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Plx Pharma Inc achieved highest sequential Net Cash Flow growth. While Plx Pharma Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Plx Pharma Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Cash Flow 12 Months Ending $ -56.72 $ -44.44 $ -31.92 $ 46.94 $ 73.47
Y / Y Net Cash Flow Growth (TTM) - - - 455.71 % -
Year on Year Net Cash Flow Growth Overall Ranking # 139 # 0 # 0 # 170 # 0
Seqeuential Net Cash Flow Change (TTM) - - - -36.1 % 9.8 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 373 # 0 # 0 # 788 # 95




Cumulative Net Cash Flow growth Comment
Plx Pharma Inc realized trailing twelve months net cash outflow of $ -57 millions, in the Sep 30 2022, compare to Net Cash Flow of $ 73 millions a year ago.

Within the Healthcare sector 26 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 139.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
455.71 %
-123.42 %
-577.78 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 27
Overall # 139

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
455.71 %
184.25 %
-87.22 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 32
Sector # 67
S&P 500 # 373
Cumulative Net Cash Flow growth Comment
Plx Pharma Inc realized trailing twelve months net cash outflow of $ -57 millions, in the Sep 30 2022, compare to Net Cash Flow of $ 73 millions a year ago.

Within the Healthcare sector 26 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 139.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
455.71 %
-123.42 %
-577.78 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 27
Overall # 139

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
455.71 %
184.25 %
-87.22 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 32
Sector # 67
S&P 500 # 373




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
PLXP's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for PLXP's Competitors
Net Cash Flow Growth for Plx Pharma Inc 's Suppliers
Net Cash Flow Growth for PLXP's Customers

You may also want to know
PLXP's Annual Growth Rates PLXP's Profitability Ratios PLXP's Asset Turnover Ratio PLXP's Dividend Growth
PLXP's Roe PLXP's Valuation Ratios PLXP's Financial Strength Ratios PLXP's Dividend Payout Ratio
PLXP's Roa PLXP's Inventory Turnover Ratio PLXP's Growth Rates PLXP's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2022
Horizon Therapeutics Public Limited Company-7.13%$ -7.126 millions
Abbvie inc -8.94%$ -8.938 millions
Reflect Scientific Inc -10.82%$ -10.823 millions
Integra Lifesciences Holdings Corp-11.03%$ -11.030 millions
Ngm Biopharmaceuticals Inc -12.70%$ -12.705 millions
Monte Rosa Therapeutics Inc -13.05%$ -13.054 millions
Ironwood Pharmaceuticals inc -13.90%$ -13.897 millions
Sep Acquisition Corp -14.18%$ -14.181 millions
Harmony Biosciences Holdings inc -17.35%$ -17.350 millions
Amgen Inc -19.48%$ -19.479 millions
Relmada Therapeutics Inc -22.37%$ -22.367 millions
Teleflex Incorporated-25.34%$ -25.336 millions
Semler Scientific Inc -25.80%$ -25.799 millions
Kiora Pharmaceuticals Inc-27.15%$ -27.153 millions
American Bio Medica Corporation-27.27%$ -27.273 millions
Axim Biotechnologies Inc -27.61%$ -27.615 millions
Tcr2 Therapeutics Inc -28.60%$ -28.597 millions
Enliven Therapeutics Inc -30.72%$ -30.725 millions
Utah Medical Products Inc-31.73%$ -31.734 millions
Tenaya Therapeutics Inc -32.90%$ -32.897 millions
Tandem Diabetes Care Inc -36.07%$ -36.073 millions
Achari Ventures Holdings Corp I-37.88%$ -37.882 millions
Cadre Holdings Inc -39.62%$ -39.623 millions
Bionexus Gene Lab Corp -43.99%$ -43.986 millions
Vaxxinity Inc -46.28%$ -46.279 millions
Plus Therapeutics Inc -47.17%$ -47.172 millions
Seres Therapeutics Inc -48.80%$ -48.798 millions
Fate Therapeutics Inc -48.94%$ -48.943 millions
Myovant Sciences Ltd -51.54%$ -51.540 millions
Imaging Diagnostic Systems Inc-51.83%$ -51.826 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com